Evidence map›Paper›PMID 27224643›Full record

Trial reportPloS one2016

Abdominal Obesity, Race and Chronic Kidney Disease in Young Adults: Results from NHANES 1999-2010.

Harini Sarathy, Gabriela Henriquez, Matthew K Abramowitz, Holly Kramer, Sylvia E Rosas, Tanya Johns, Juhi Kumar, Amy Skversky, Frederick Kaskel, Michal L Melamed

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
9.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Obesity-related glomerulopathy: Current approaches and future perspectives.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Harini SarathyDepartment of Medicine, Albert Einstein College of Medicine / Montefiore Medical Center, Bronx, New York, United States of America.
Gabriela HenriquezDepartment of Medicine, Albert Einstein College of Medicine / Montefiore Medical Center, Bronx, New York, United States of America.
Matthew K AbramowitzDepartment of Medicine, Albert Einstein College of Medicine / Montefiore Medical Center, Bronx, New York, United States of America.
Holly KramerDepartments of Public Health Sciences and Medicine, Division of Nephrology and Hypertension, Loyola University Health Sciences Center, Maywood, Illinois, United States of America.
Sylvia E RosasJoslin Diabetes Center and Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Tanya JohnsDepartment of Medicine, Albert Einstein College of Medicine / Montefiore Medical Center, Bronx, New York, United States of America.
Juhi KumarDepartment of Pediatrics, Weill Cornell Medical Center, New York, New York, United States of America.
Amy SkverskyDepartment of Pediatrics, Albert Einstein College of Medicine / Montefiore Medical Center, Bronx, New York, United States of America.
Frederick KaskelDepartment of Pediatrics, Albert Einstein College of Medicine / Montefiore Medical Center, Bronx, New York, United States of America.
Michal L MelamedDepartment of Medicine, Albert Einstein College of Medicine / Montefiore Medical Center, Bronx, New York, United States of America.
Montefiore Medical Center · USAlbert Einstein College of Medicine · USCornell University · USJoslin Diabetes Center · USLoyola Medicine · US

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Irwin Jack Kurland · 2015 to 2026
$27.7M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
DEVELOPMENTAL RENAL AND ELECTROLYTE PHYSIOLOGYT32DK007110 · NIDDK · YESHIVA UNIVERSITY · PI KASKEL, FREDERICK JEFFREY, MELAMED, MICHAL L · 1986 to 2021
$5.6M
Effects of Vitamin D and Fish Oil on the Kidney in HypertensivesR01DK102952 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MELAMED, MICHAL L · 2015 to 2019
$3.8M
Inflammation, muscle wasting, and physical function in chronic kidney diseaseK23DK099438 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ABRAMOWITZ, MATTHEW K · 2014 to 2018
$946k
Vitamin D hormones in CKiD: Prevalence of deficiency and clinical correlates.K23DK084339 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI KUMAR, JUHI · 2009 to 2013
$775k
Group-based Chronic Kidney Disease CareR34DK102174 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MELAMED, MICHAL L · 2014 to 2015
$752k
NCATS NIH HHS UL1 TR001073NIDDK NIH HHS K23 DK084339NIDDK NIH HHS K23 DK099438NIDDK NIH HHS P30 DK020541NIDDK NIH HHS R01 DK102952NIDDK NIH HHS R34 DK102174NIDDK NIH HHS T32 DK007110
6 · The paper itself

Abstract

objectiveKidney dysfunction in obesity may be independent of and may precede the development of hypertension and/or diabetes mellitus. We aimed to examine if abdominal obesity is associated with early markers of CKD in a young healthy population and whether these associations differ by race and/or ethnicity.

methodsWe analyzed data from the NHANES 1999-2010 for 6918 young adults ages 20-40 years. Abdominal obesity was defined by gender criteria of waist circumference. CKD markers included estimated glomerular filtration rate and albuminuria ≥30 mg/g. Race stratified analyses were done overall and in subgroups with normal blood pressures, normoglycemia and normal insulin sensitivity. Awareness of CKD was assessed in participants with albuminuria.

resultsAbdominal obesity was present in over one-third of all young adults and was more prevalent among non-Hispanic blacks (45.4%) versus Mexican-Americans (40.6%) or non-Hispanic whites (37.4%) (P-value = 0.004). Mexican-American young adults with abdominal obesity had a higher odds of albuminuria even among those with normal blood pressure, normal glucose, and normal insulin sensitivity [adjusted odds ratio 4.5; 95% confidence interval (1.6-12.2), p = 0.004]. Less than 5% of young adults with albuminuria of all races and ethnicities had been told they had kidney disease.

conclusionAbdominal obesity in young adults, especially in Mexican-Americans, is independently associated with albuminuria even with normal blood pressures, normoglycemia and normal insulin levels. Greater awareness of CKD is needed to protect this young population from long-standing exposure to abdominal obesity and early progressive renal disease.

Indexed as

Body Mass IndexIntra-Abdominal FatObesity, AbdominalRacial GroupsRenal Insufficiency, ChronicAbsorptiometry, PhotonAdultFemaleHumansMaleMiddle AgedSex FactorsYoung Adult

Identifiers

PMID27224643
PMCPMC4880194
OpenAlexW2406960482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.